Evidence map›Paper›PMID 34275111›Full record

ArticleHepatology international2021

Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure.

Nipun Verma, Radha Krishan Dhiman, Ashok Choudhury, Sunil Taneja, Ajay Duseja, Virender Singh, Mamun Al Mahtab, Harshad Devarbhavi, Akash Shukla, Q Ning and 35 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 11 countries.

Nipun VermaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Radha Krishan DhimanDepartment of Hepatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. rkpsdhiman@hotmail.com.
Ashok ChoudhuryDepartment of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Sunil TanejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ajay DusejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Virender SinghDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Mamun Al MahtabDepartment of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Harshad DevarbhaviDepartment of Hepatology, St John Medical College, Bangalore, India.
Akash ShuklaDepartment of Gastroenterology, Lokmanya Tilak Municipal General Hospital, and Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India.
Q NingInstitute and Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Saeed Sadiq HamidDepartment of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Amna Shubhan ButtDepartment of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Wasim JafriDepartment of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Soek Siam TanDepartment of Medicine, Hospital Selayang, Bata Caves, Selangor, Malaysia.
Jinhua HuDepartment of Medicine, 302 Military Hospital, Beijing, China.
Duan ZhongpingTranslational Hepatology Institute Capital Medical University, Beijing You'an Hospital, Beijing, China.
Sombat TreeprasertsukDepartment of Medicine, Chulalongkorn University, Bangkok, Thailand.
Guan H LeeDivision of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore.
Hasmik GhazinyanDepartment of Hepatology, Nork Clinical Hospital of Infectious Disease, Yerevan, Armenia.
Laurentius A LesmanaDigestive Disease and GI Oncology Centre, Medistra Hospital, Jakarta, Indonesia.
Ajit SoodDepartment of Gastroenterology, DMC, Ludhiana, India.
Vandana MidhaDepartment of Gastroenterology, DMC, Ludhiana, India.
Omesh GoyalDepartment of Gastroenterology, DMC, Ludhiana, India.
Dong Joon KimDepartment of Internal Medicine, Hallym University College of Medicine, Seoul, South Korea.
C E EapenDepartment of Hepatology, CMC, Vellore, India.
Ashish GoelDepartment of Hepatology, CMC, Vellore, India.
Han TaoDepartment of Hepatology and Gastroenterology, The Third Central Clinical College of Tianjin Medical University, No. 83, Jintang Road, Hedong District, Tianjin, 300170, China.
Xin ShaojieLiver Failure Treatment and Research Center, The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, China.
Nan YueminDepartment of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, China.
A Kadir DokmeciDepartment of Medicine, Ankara University School of Medicine, Ankara, Turkey.
Manoj SahuDepartment of Gastroenterology and Hepatology Sciences, IMS and SUM Hospital, Bhubaneswar, Odisha, India.
Ayaskanta SinghDepartment of Gastroenterology and Hepatology Sciences, IMS and SUM Hospital, Bhubaneswar, Odisha, India.
Anil AroraInstitute of Liver Gastroenterology and Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, New Delhi, India.
Ashish KumarInstitute of Liver Gastroenterology and Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, New Delhi, India.
Ramesh KumarDepartment of Gastroenterology, All India Institute of Medical Sciences, Patna, Bihar, India.
V G Mohan PrasadDepartment of Gastroenterology, VGM Hospital, Coimbatore, India.
Ananta ShrestaDepartment of Hepatology, Foundation Nepal Sitapaila Height, Kathmandu, Nepal, India.
Jose SollanoDepartment of Medicine, Cardinal Santos Medical Center, Manila, Philippines.
Diana Alcantara PayawalFatima University Medical Center Manila, Manila, Philippines.
Samir ShahGlobal Hospitals, Mumbai, India.
P N RaoAsian Institute of Gastroenterology, Hyderabad, India.
Anand KulkarniAsian Institute of Gastroenterology, Hyderabad, India.
George K LauDepartment of Medicine, Humanity, and Health Medical Group, Hong Kong, People's Republic of China.
Shiv Kumar SarinDepartment of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party
Post Graduate Institute of Medical Education and Research · INAga Khan University Hospital · PKAsian Institute of Gastroenterology · INChristian Medical College & Hospital · INInstitute of Liver and Biliary Sciences · INInstitute of Medical Sciences and Sum Hospital · INSir Ganga Ram Hospital · IN302 Military Hospital of China · CNAll India Institute of Medical Sciences · INAnkara University · TRBangabandhu Sheikh Mujib Medical University · BDBeijing YouAn Hospital · CNChinese PLA General Hospital · CNChulalongkorn University · THGlobal Hospitals · INHallym University · KRHospital Selayang · MYHumanity & Health · CNKG Hospital · INLokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe evaluated the dynamics of hepatic encephalopathy (HE) and ammonia estimation in acute-on-chronic liver failure (ACLF) patients due to a paucity of evidence.

methodsACLF patients recruited from the APASL-ACLF Research Consortium (AARC) were followed up till 30 days, death or transplantation, whichever earlier. Clinical details, including dynamic grades of HE and laboratory data, including ammonia levels, were serially noted.

resultsOf the 3009 ACLF patients, 1315 (43.7%) had HE at presentation; grades I-II in 981 (74.6%) and grades III-IV in 334 (25.4%) patients. The independent predictors of HE at baseline were higher age, systemic inflammatory response, elevated ammonia levels, serum protein, sepsis and MELD score (p < 0.05; each). The progressive course of HE was noted in 10.0% of patients without HE and 8.2% of patients with HE at baseline, respectively. Independent predictors of progressive course of HE were AARC score (≥ 9) and ammonia levels (≥ 85 μmol/L) (p < 0.05; each) at baseline. A final grade of HE was achieved within 7 days in 70% of patients and those with final grades III-IV had the worst survival (8.9%). Ammonia levels were a significant predictor of HE occurrence, higher HE grades and 30-day mortality (p < 0.05; each). The dynamic increase in the ammonia levels over 7 days could predict nonsurvivors and progression of HE (p < 0.05; each). Ammonia, HE grade, SIRS, bilirubin, INR, creatinine, lactate and age were the independent predictors of 30-day mortality in ACLF patients.

conclusionsHE in ACLF is common and is associated with systemic inflammation, poor liver functions and high disease severity. Ammonia levels are associated with the presence, severity, progression of HE and mortality in ACLF patients.

Indexed as

Acute-On-Chronic Liver FailureHepatic EncephalopathyAmmoniaHumansLiver CirrhosisPrognosisSeverity of Illness IndexAmmoniaACLFAltered sensoriumCirrhosisDeliriumHepatic comaLiver failureNatural historyOutcomesPredictive modelsSurvival

Identifiers

PMID34275111
OpenAlexW3183751837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.